Aneurysmal subarachnoid haemorrhage—cerebral vasospasm and prophylactic ibuprofen: a randomised controlled pilot trial protocol

INTRODUCTION: Cerebral vasospasm (CVS) is the leading cause of mortality and morbidity following aneurysmal subarachnoid haemorrhage (aSAH). One of the recently implicated underlying mechanisms of CVS is inflammatory cascades. Specific feasibility objectives include determining the ability to recrui...

Descripción completa

Detalles Bibliográficos
Autores principales: Dayyani, Mojtaba, Mousavi Mohammadi, Ermia, Ashoorion, Vahid, Sadeghirad, Behnam, Javedani Yekta, Mohammadreza, Grotta, James C, Gonzalez, Nestor R, Zabihyan, Samira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006795/
https://www.ncbi.nlm.nih.gov/pubmed/35414560
http://dx.doi.org/10.1136/bmjopen-2021-058895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006795/
https://www.ncbi.nlm.nih.gov/pubmed/35414560
http://dx.doi.org/10.1136/bmjopen-2021-058895

Ejemplares similares